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0022-2836 © 2012 Elsevier Ltd. Open accStable RNA–DNA hybrids formed by invasion of an RNA strand into
duplex DNA, termed R-loops, are notorious for provoking genome
instability especially when they arise during transcription. However, in
some instances (DNA replication and class switch recombination), R-loops
are useful so long as their existence is carefully managed to avoid them
persisting. A recent ﬂow of research papers establishes a newly discovered
use for R-loops as key intermediates in a prokaryotic immune system called
CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats).
Structures and mechanism of ribonucleoprotein complexes (“Cascades”)
that form CRISPR R-loops highlight precision targeting of duplex DNA that
has sequence characteristics marking it as foe, enabling nucleolytic
destruction of DNA and recycling the Cascade. We review these signiﬁcant
recent breakthroughs in understanding targeting/interference stages of
CRISPR immunity and discuss questions arising, including a possible link
between targeting and adaptive immunity in prokaryotes.© 2012 Elsevier Ltd. Open access under CC BY license.RNA–DNA Hybrids and R-Loops
Double-helical structures of B-form DNA and A-
form RNA were reported in the 1950s,1–4 but to
satisfy the central “dogma” of molecular biology
(“DNAmakes RNAmakes protein”), it was apparent
that RNA–DNA hybrids might need to form. This
was shown to be possible in 1960,5 and their atomic
structures show stable duplex that is closer in
dimensions to A-form helix.6 Physiological relevance
of natural RNA–DNA hybrids has been described in
several contexts, summarised in Table 1. Most
familiar are hybrids formed during transcriptioness:
le‐stranded DNA;
NA, CRISPR RNA;
, protospacer adjacent
ess under CC BY license.andDNA replication. Atomic resolution structures of
RNA polymerase transcription complexes show
short (12–20 bp) RNA–DNA hybrids.17–19 The
hybrids are transient as structural features of RNA
polymerases and proximity of RNA binding proteins
(e.g., for translation) steward nascent RNA away
from template DNA.20,21 Transient RNA–DNA
hybrids are also characteristic of DNA replication,
as Okazaki fragments at replication fork lagging
strands22,23 and in tRNAprimedDNA synthesis by a
reverse transcriptase ﬁrst reported in 1970.24,25
RNA–DNA hybrids are sometimes stabilised as R-
loops, deﬁned as an RNA strand invaded into
duplex DNA, base pairing with one DNA strand
and displacing the other as a single‐stranded DNA
(ssDNA) loop (Fig. 1). The name R-loop is used
because of the resemblance of these molecules to
strand invasion intermediates of homologous re-
combination called D-loops, which are composed
solely of DNA. R-loops themselves are implicated in
a specialised type of recombination, site-speciﬁc
Table 1. Physiological relevance of R-loops in biology
Process RNA–DNA hybrid/R-loop Details
Transcription Nascent RNA synthesis from
DNA templates“Thread-back” and
“extended hybrid” models of R-loop
persistence during transcription
7, 8
Epigenetics:
methylation
Protection of CpG promoter islands
from methylation
9
DNA replication Priming of lagging strand
synthesis.Priming of plasmid (ColE1),
viral and mitochondrial replication
10–13
Genome
instability
R-loops provoking illegitimate
recombination
8, 14
CSR R-loops at G‐rich sequence provoke
immunoglobulin diversity
15
Telomere
processing
“t-loop” of RNA and G‐rich DNA 16
CRISPR
targeting
R-loop of crRNA targeting
invasive DNA
This
work
Table 2. Proteins that prevent, control and reverse R-loop
formation
Protein Activity Details
RNaseHI Ribonuclease on RNA
strands base paired to DNA
29
Topoisomerase I Relaxation of negatively
supercoiled DNA
30, 31
RecG Helicase unwinding R-loops 32
Pif1 Helicase unwinding
RNA–DNA hybrids
33
Senataxin/Sen1 Helicases unwinding
RNA–DNA hybrids
34
Various transcription
termination and mRNA
processing factors
Bind to nascent RNA to
prevent thread-back R-loops
8
Cas3 Helicase unwinding R-loops 35
608 Review: CRISPR Interference and R-Loopsclass switch recombination (CSR) in vertebrate
immune systems.15 Guanine-rich DNA sequences
are important for initiating R-loop formation in
CSR, and DNA negative supercoiling is another key
context that promotes R-loop formation.7,26 R-loops
were ﬁrst identiﬁed at bacterial ColE1 plasmid
origins of replication,27 and similar mechanisms
prime replication in mitochondria10 and viruses.11
R-loops were also seen in in vitro transcription
reactions28 that led to many more studies establish-
ing the importance of RNaseH in removing R-loops
after initiation of replication and of DNA topo-
isomerase I preventing R-loop formation during
transcription, summarised in Table 2. The impor-
tance of R-loop management in cells is made clear
by studies showing mutagenic effects of persistent
R-loops through conﬂict with DNA replication and
provoking of illegitimate homologous recombina-
tion, reviewed recently.8
Here, we focus on a protein–RNA complex that
forms R-loops by a precise targeting mechanism
guided to duplex DNA. The mechanism is a part of
CRISPR/Cas immunity, a newly discovered system
in bacteria and archaea that can seek and destroyinvasive nucleic acids from virus or plasmid.
Emergence of CRISPR/Cas has been striking, not
least because its mechanisms are underpinned by
adaptive immunity that is expressed in RNA
sequences. We highlight some exciting recent work
that has provided elegant detail for CRISPR/Cas
targeting to DNA, using protein–RNA complexes
from bacteria and archaea, and aim to unify this
with more general interest in R-loops.8Discovery of CRISPR/Cas RNA-Based
Immunity in Bacteria and Archaea
The bedrock of CRISPR/Cas systems is repetitive
DNA sequence in prokaryotes called CRISPR (Clus-
tered Regularly Interspersed Short Palindromic
Repeats). The name CRISPR was ﬁrst used in
2002,36 but Escherichia coli CRISPRs were noted
earlier as unusual sequence repeats proximal to a
gene encoding an alkaline phosphatase isozyme
(iap).37 Similar short repetitive sequences under
different names were described in bacteria and
archaea,38–40 distinguished by signiﬁcant differ-
ences to other classes of widespread short sequence
repeats in bacteria, ERICs and REPs. In a landmarkFig. 1. (a) R-loops are charac-
terised by invasion of an RNA
strand into duplex DNA via base
pairing with one DNA strand
thereby displacing the other as
ssDNA. For simplicity, R-loops are
often drawn as in (b).
Fig. 2. Major processes in CRISPR systems (adaptation, expression and interference/targeting) summarised with
emphasis on Cascade systems that target duplex DNA with crRNA. See the text for details. A CRISPR locus, comprising
spacers (S), repeats (R) and a promoter/leader sequence, is the source of RNA message (pre-crRNA) that is processed by
Cascade into crRNA to form a ribonucleotide–protein complex. Cascade catalyses targeting of DNAwith crRNA, detailed
in Fig. 3. Targeting results in R-loop intermediates and recruitment of Cas3 nuclease–helicase, processes that might be
linked to generation of DNA fragments (protospacers) for incorporation into CRISPR as spacers by unknown
mechanisms.
609Review: CRISPR Interference and R-Loopspaper,36 comparison of these new sequence re-
peats in multiple species brought on the name
CRISPR, deﬁned by two factors: (a) Sequence
repeats of 20–30 nt are interspersed with “spacers”
of variable non-repeat sequence of 20–75 nt. (b)
CRISPR associated (Cas) proteins that are con-
served in many organisms with amino acid motifs
characteristic of nucleic acid processing enzymes
(Fig. 2). Signiﬁcantly, at about the same time,
CRISPR RNA (crRNA) transcripts that were much
shorter than full-length CRISPR loci were detected,
suggesting endonucleolytic processing of crRNA.43
At that point, the prevailing mood was that
CRISPR/Cas, particularly Cas proteins, cooperated
in DNA replication, recombination and repair.44–46
Observations in bacteria and archaea that the non-
repeat spacers within CRISPR matched sequences
from plasmids, phages and prophages,47–49 stimu-
lated a new hypothesis: CRISPR provides defence
against viruses in archaea50 through an immune
system based on RNAi (RNA interference)-like
mechanisms.51 In 2007, experimental manipulation
of CRISPR spacer sequences in Streptococcus
thermophilus DGCC7710, an important bacterium
for the dairy industry, was shown to protect cells
from decimation by phage, dependent on a then
unknown activity of a Cas protein (Cas5, now
called Cas9/Csn1).42
How Does CRISPR Work? Multifarious
Nucleic Acid Processing
CRISPR/Cas systems are genetically diverse and
show extensive variation in composition of encoded
proteins. S. thermophilusDGCC7710 exempliﬁes this,
possessing four CRISPR/Cas systems (CRISPR‐1–CRISPR‐4) each with different complements of Cas
proteins.52,53 The common theme in each system is
the presence of a CRISPR locus, although there is
variation in the number of repeats and repeat/
spacer sequence composition. However, conserva-
tion of underlying principles of CRISPR immunity
in different species was shown recently, by intro-
duction of S. thermophilus CRISPR-3 into E. coli
conferring heterologous protection against plasmid
and phage.53
CRISPR/Cas systems have undergone two itera-
tions of classiﬁcation based on Cas protein distribu-
tion that is subdivided into three types (I, II and
III).54,55 This is reﬂected in major mechanistic
differences in how CRISPR sequences are manipu-
lated for immunity and protection. Overall, in all
systems, CRISPR/Cas operates through three major
processes, each catalysed by distinct nucleic acid
processing enzymes (Fig. 2): (a) adaptation, incorpo-
ration of a DNA fragment from a nonself invasive
element (called a “pre-spacer”) into a CRISPR locus
as a “spacer” alongside a new CRISPR repeat, and
(b) transcription and processing of crRNA to arm a
protein complex for (c) interference/targeting of
nucleic acid sequence, called a “protospacer” if the
target is DNA, by homologous sequence in crRNA
leading to destruction of the invasive plasmid or
phage.
Recent reviews detail these processes and regula-
tion of cas genes and CRISPR.52,56–61 In summary,
adaptation is poorly understood, but CRISPR loci
can acquire new spacer sequence derived from
nonself DNA, alongside a new repeat, in response
to exposure to phage.62–64 In the E. coli type I
CRISPR system, adaptation relies on nucleases Cas1
and Cas265,66 through unknown mechanisms in
which protospacer is directed for incorporation as a
610 Review: CRISPR Interference and R-Loopsspacer.67 Adaptation in the type II CRISPR system
(CRISPR-3) of S. thermophilus requires Csn2 protein,
also by unknown mechanisms.41,42,68,69
Transcription of CRISPR from an AT‐rich leader
sequence generates precursor crRNA (pre-crRNA),
which is endonucleolytically shortened into mature
crRNA by cleavage in repeat sequences. Two major
nuclease groups, Cas6 and Cas9, catalyse crRNA
formation, depending on the particular CRISPR/
Cas system: using the nomenclature of reference,55
these are called Cas6,70,71 Cas6e (previously called
CasE and Cse3),72–74 Cas6f (previously, Csy4)75 and
Cas9–RNase III complex.76 crRNA is used to target
foreign nucleic acid by protein complexes that
guide it to complementary nucleotide sequence. In
archaeal type III CRISPR systems of Pyrococcus
furiosus and Sulfolobus solfataricus, crRNA is held in
a complex called CMR77–79 (Cas module RAMP,
where RAMP was originally used to mean Repeat‐
Associated Mysterious Proteins51). CMR targets
crRNA to other RNA molecules, presumed to be
viral mRNA, which are cleaved with mechanistic
differences between P. furiosus and S. solfataricus
CMR.77–79 In the next sections, we focus on CRISPR
interference strategies that use crRNA to target
duplex DNA in stable DNA–RNA hybrids. Emerg-
ing evidence suggests two main routes for this, each
requiring different Cas proteins: Cas9 protein typical
of type II CRISPR systems or a multi-protein
complex called Cascade, synonymous with the
interference stage of type I CRISPR systems.crRNA to Target DNA: Cas9 and Cascade
Cas9
First models of CRISPR/Cas as a prokaryotic
immunity system suggested that Cas proteins
manipulate crRNA to target invading RNA, simi-
larly to RNAi in eukaryotes.51 CMR complexes do
target RNA, as noted in the previous section.
Similarities and distinctions between CRISPR sys-
tems and eukaryotic RNAi have been reviewed
recently.61 Other CRISPR/Cas systems use crRNA
to target DNA. Before biochemical mechanisms of
crRNA–DNA targeting came to light, it was known
that spacer sequences transcribed to crRNA in the
bacterium S. thermophilus match phage DNA
sequence from both coding and template strands,47
suggesting targeting of either strand of phage DNA.
This was also inferred in E. coli, in experiments using
an engineered CRISPR/Cas system to protect
against phage λvir,72 and in Staphylococcus epidermi-
dis. In the latter, a nickase gene from a conjugative
plasmid could be blocked by a CRISPR system at the
level of DNA but not mRNA.80 Crucially, another
study in S. thermophilus showed that double‐stranded DNA is targeted rapidly (b2 min) by
CRISPR/Cas, by a mechanism that required Cas5
(now called Cas9), resulting in nuclease degradation
of target DNA.81 An absolute requirement for S.
thermophilus Cas9 in CRISPR targeting to plasmid
DNA was conﬁrmed later.53 Cas9 may also have a
role in RNaseIII‐mediated processing of pre-crRNA
to crRNA in some species.76 Not much is known
about the structure or function of Cas9 protein. It is a
large protein (N1200 amino acids) with conserved
motifs typical of RuvC/RNaseH nucleases that are
needed for Cas9 function in vivo.53 Perhaps, Cas9
multitasks, contributing to preparation of crRNA
that is retained for targeting and destruction of DNA
in a way analogous to Cascade complexes, which we
now look at in detail.
Cascade: A crRNA interference complex in type I
systems
Cascade (CRISPR‐Associated Complex for Anti-
viral Defence) is a multi-protein ribonucleic acid
complex that forms R-loops with complementary
DNA sequence, catalysing interference stages of
CRISPR immunity in bacteria and archaea. The
complex was identiﬁed in E. coli, in which it remains
tightly bound to crRNA that it has formed from pre-
crRNA by endonucleolytic cleavage.72 In the same
study an important proof of principle was reported;
co-expression of Cascade with a crRNA construct
complementary to viral DNA, as well as an
additional protein (Cas3), was sufﬁcient to give
robust protection of E. coli cultures against plaque
formation by phage λvir. The use of ectopic
expression of these individual components from
plasmids in an E. coli strain lacking cas genes was
prescient, side-stepping BaeSR, H-NS/LeuO‐medi-
ated transcriptional regulation of E. coli CRISPR/cas
that subsequently came to light.82–84 The hypothesis
that crRNA is targeted to viral DNA of either strand,
involving Cascade and Cas3 proteins that are
widely distributed in type I CRISPR systems, was
established.
E. coli Cascade comprises ﬁve proteins, originally
called CasABCDE,72 now Cse1(CasA), Cse2(CasB),
Cas7(CasC), Cas5(CasD) and Cas6e(CasE). All of
these are required to protect E. coli cells against lytic
phage in plaque assays.85 A remarkable sequence of
work in the last few years has established how E. coli
Cascade forms R-loops. These principles probably
translate into other Cascade complexes, based on
functional studies of a Cas5–Cas7–crRNA complex
in S. solfataricus,86 an archaeal species that also
processes crRNA within a CMR complex,79 and
studies of Pseudomonas aeruginosa PA14 Csy1–Csy4
(now called Csy1, Csy2, Csy3 and Cas6f),87 which
has structural similarities to Cascade from E. coli85
despite there being little sequence similarity be-
tween the respective proteins.
Fig. 3. Life cycle of a bacterial
Cascade complex, using E. coli as a
model system. See the main text for
details. For clarity of labelling, pro-
teins of the Cascade complex are
labelled CasABCDE, as in Ref. 41,
instead of using recently adopted
nomenclature, explained in the text
(from Ref. 42). (a) CasA (Cse1) is
crucial for initial interaction of
Cascade with target DNA of com-
plementary seed sequence. (b) This
results in some rearrangement of
proteins CasB and CasE (Cse2 and
Cas6e) and extensive base pairing
of crRNA with target DNA and R-
loop formation. (c) Cas3 is recruited
to targeting complex via interaction
with CasA and can load onto 3′ ended ssDNA enabling its DNA nicking, nuclease and ATP-dependent 3′‐to‐5′
translocase activities to degrade the DNA target (d). This may also provide the mechanism for release of Cascade from
target DNA with crRNA in tact for subsequent interference reactions.
611Review: CRISPR Interference and R-LoopsE. coli Cascade has a stoichiometry of 1:2:6:1:1
(Cse1:Cse2:Cas7:Cas5:Cas6e) in a 405‐kDa protein
complex bound to crRNA.85 This crRNA comprises
a 32‐nt spacer core ﬂanked with an 8‐nt 5′ handle
and a 21‐nt 3′ hairpin loop. The overall morphology
of Cascade, described as a seahorse,85 has a
prominent backbone of six Cas7 subunits within
which a crRNA cord dictates assembly of Cas7 as a
nucleoprotein helix.88 Filamentous Cas7 backbone is
also clear when imaged from S. solfataricus.86 A 5′
end crRNA hook neatly delimits assembly of
multiple Cas7 subunits through interaction with
the sixth Cas7 subunit.88 Cse1 is also proximal to the
5′ hook. At the other end of the complex is Cas6e, the
Cascade ribonuclease that remains bound to crRNA
3′ end, which is a hairpin loop in E. coli.
A Recipe for R-Loops: Cascade, PAM,
Seeds and Supercoils
Cascade establishes an R-loop by base pairing
crRNA to protospacer DNA that has sequence and
structure betraying it as a bona ﬁde target (Fig. 3).
Cascade and Csy1–Csy4 operate a policy of selective
engagement with DNA, triggering R-loop formation
when encountering “seed” sequence and, at least in
the E. coli system, a protospacer adjacent motif
(PAM). The seed sequence is probably a common
mechanism in all crRNA–DNA pairing through
thermodynamic considerations, offering aminimum
length requirement for a stable RNA–DNA hybrid
forming at the 5′ end of crRNA that displaces an
unpaired DNA strand in an R-loop. Similar seeding
is responsible for RNA–RNA pairing by Argonautes
in eukaryotic RNAi61 and is important for both
Cascade and Csy1–Csy4 complexes.87,89 Similaritieshave been noted in structure and function of
nucleoprotein ﬁlaments formed by archaeal Cas7–
crRNA and the bacterial recombinase RecA in
complex with ssDNA.86 RecA ﬁlaments catalyse
pairing with homologous duplex DNA forming D-
loops from seed sequences, and it may be the case
that similar forces apply in R-loop formation by
Cascades.
In contrast to seeding of R-loop formation, in
ways probably common in other biological pro-
cesses, PAMs can give CRISPR interference se-
quence speciﬁcity. PAMs are typically of 2–3 nt,
upstream of protospacer DNA, and they do not
match crRNA sequence. Originally, PAMs were
recognised as a pattern of nucleotide motifs
juxtaposed to protospacer/pre-spacer sequence of
invasive DNA in S. thermophilus and other CRISPR
loci.47,63,90,91 In E. coli, where a trinucleotide PAM is
located at positions −3 to −1 relative to crRNA–
protospacer base pairing, substitutions to PAM in
M13 phage allowed escape from E. coli Cascade
targeting, measured as efﬁciency of plaque forma-
tion on E. coli cell lawns.89 The presence, absence or
manipulation of PAM sequence in plasmid targets
resulted in altered efﬁciency of binding by puriﬁed
E. coli Cascade.92 Dissociation constants (Kd) were
at least 19 times higher for Cascade binding a
negatively supercoiled plasmid lacking PAM com-
pared to the same plasmid with a PAM and 3 times
higher when PAM sequence was altered to an
escape sequence that had been identiﬁed in E. coli
by plaque assays.89
It had been noted previously that DNA binding
by E. coli Cascade relied on its Cse1 subunit85 and
that target binding by Cascade can result in
movement of Cse1 (as well as Cse2 and Cse6e)
relative to the Cas7 backbone.88 Mechanistic detail
612 Review: CRISPR Interference and R-Loopsof Cse1 function is now available from biochemis-
try of E. coli Cascade and the crystal structure of
Cse1 from T. thermophilus.93 The key to Cse1 in this
instance is a trio of amino acids that includes a
phenylalanine forming a loop (L1) that is needed
for effective protection by Cascade in vivo and is
positioned such that it might recognise PAM and
destabilise target duplex. Interestingly, Sulfolobus
Cascade lacks a clear sequence homologue of Cse1
yet PAM sequences are important for targeting
reactions in this organism.86,94 P. aeruginosa Csy1–
Csy4 lacks Cse1 and shows only sequence‐speciﬁc
DNA binding, requiring the seed DNA sequence.
These recent insights into Cascade molecular
biology indicate how this nucleoprotein complex
sets up an R-loop by distinguishing nonself DNA
from self and scanning for seeding sites.
Recent work revealed an elegant solution to how
E. coli Cascade gains energy for scanning, seeding
and conformational movements: negatively super-
coiled DNA.92 The chromosome of E. coli is
maintained in a negatively supercoiled state. It is
well known that hypernegative supercoiling pro-
motes R-loop formation globally in bacteria, which
causes cell inviability if supercoils are not relaxed by
topoisomerase I.8 Cascade provides the means to
exploit this in a targeted way, once it has established
that DNA is nonself by mechanisms described
above. All that is then left to do is destroy target
DNA. This is less well understood, but recent work
has conﬁrmed that interaction of Cascade with Cas3
protein facilitates this.How to Destroy an R-Loop: Cas3
Nuclease–Helicase
Interplay between Cas3 and Cascade in protection
against phage λvir was identiﬁed in E. coli.72
Subsequent biochemical studies were above all in
other species because of instability of E. coli Cas3 for
puriﬁcation unless fused to maltose binding
protein35 or more recently to Cse1.92 The latter
work conﬁrmed that E. coli Cas3 is a nuclease active
against ssDNA, with both exonuclease and endo-
nuclease activities residing in an HD domain, in
agreement with nuclease activities of other Cas3
proteins.95–98 In addition to HD nuclease activity,
Cas3 has superfamily 2 helicase motifs that power
ATP-dependent translocation 3′ to 5′ along
ssDNA,98 through R-loops.35 Cas3 translocation
stimulates exonuclease activity,92,95 consistent with
a multitasking machine that can processively de-
grade the invasive target DNA (Fig. 3). Fusion of E.
coli Cas3 with Cse1 for in vitro studies efﬁciently
targeted Cas3 nuclease to plasmid DNA with PAM
and seed sequences and mimics strong evidence for
physical interaction of Cse1 with Cas3 in E. coli.92Summary Remarks: CRISPR Targeting
Linked to Spacer Acquisition?
E. coli Cascade, archaeal Cascade and Csy1–Csy4
complexes all catalyse a core process, DNA‐targeted
R-loop formation. This can be adorned by mecha-
nistic speciﬁcity arising from accessory proteins,
Cse1 and unknown partners in archaea. This is
parallel in DNA helicase–translocase superfamilies
that manipulate diverse nucleic acid structures
using speciﬁcity inducing accessory domains sur-
rounding a RecA core of ATPase domains. A
mechanistic framework for CRISPR/Cas, at least
in E. coli, is now apparent: Transcriptional activation
of CRISPR and Cascade82–84,99 sets in motion
targeting of Cascade ribonucleoprotein complex to
invasive DNA, forming a stable R-loop (Fig. 3). Cas3
is recruited via Cse1, which places it close to the 3′
tail of target DNA upstream of the crRNA–DNA
seed sequence. Cas3 nicks DNA to relax super-
coiling for robust degradation of the remaining
DNA strand using 3′‐to‐5′ ATP-dependent translo-
case–nuclease activities.
Cas3 nuclease activities can be mapped onto
crystal structures of Cas3 HD domains (called
Cas3″),95,97 but there is currently no crystal structure
of Cas3 superfamily 2 helicase domains. When this
information becomes available, it might cast some
light on some interesting conserved features at the
C-terminus of Cas3 sequences that are not canonical
helicase motifs and with no known function at
present. To understand how Cas3 is orientated onto
target DNA, it will be necessary to understand how
it interacts with Cse1: precise loading of Cas3 for
translocation 3′ to 5′ along target ssDNA would be
an effective means of displacing Cascade–crRNA
complex undamaged for recycling to subsequent
targets. It is likely that crRNA in R-loops is protected
from RNaseH, a potent nuclease against RNA in
RNA–DNA hybrids, by its extensive shielding by
the Cascade/Csy1–Csy4 backbone. A recent report
that E. coli Cas3 is a client protein for the Hsp90
protein HtpG100 offers an intriguing possibility that
Cas3, which is not co-transcribed with Cascade, is
tethered until recruited by Cse1/Cascade. This
might be a way to prevent indiscriminate DNase–
helicase activity or interaction with other cellular
proteins, but there is no information on handover of
Cas3 from HtpG to Cse1.
Does R-loop formation by Cascade and/or nucle-
ase processing by Cas3 promote acquisition of
protospacer DNA into CRISPR loci as spacers? It is
tempting to speculate that Cascade R-loops might
trigger recombination or integration of invasive
DNA into CRISPR loci akin to R-loop‐directed
CSR into repetitive switch (S) regions in mammalian
immune systems.15 S-regions, like CRISPR loci,
contain short repeats (25–80 bp) and sequence
613Review: CRISPR Interference and R-Loopsmotifs that direct recombination events downstream
of a promoter. At the time of writing, a feedback
loop between CRISPR interference and adaptation
has been suggested.67 Given how little is known
about adaptation, presumably involving at least
Cas1 and Cas2 proteins, this should prove another
interesting mechanism to work out.Acknowledgements
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